Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $106B |
| FY2017, ended Dec 31, 2017 | $140B |
| FY2018, ended Dec 31, 2018 | $110B |
| FY2019, ended Dec 31, 2019 | $102B |
| FY2020, ended Dec 31, 2020 | $101B |
| FY2021, ended Dec 31, 2021 | $101B |
| FY2022, ended Dec 31, 2022 | $66.0B |
| FY2023, ended Dec 31, 2023 | $60.4B |
| FY2024, ended Dec 31, 2024 | $70.1B |
| FY2025, ended Dec 31, 2025 | $84.3B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $84.8B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $30.1B |
| FY2017, ended Dec 31, 2017 | $31.7B |
| FY2018, ended Dec 31, 2018 | $32.8B |
| FY2019, ended Dec 31, 2019 | $32.1B |
| FY2020, ended Dec 31, 2020 | $32.2B |
| FY2021, ended Dec 31, 2021 | $35.4B |
| FY2022, ended Dec 31, 2022 | $26.2B |
| FY2023, ended Dec 31, 2023 | $24.6B |
| FY2024, ended Dec 31, 2024 | $24.6B |
| FY2025, ended Dec 31, 2025 | $24.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $25.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.05B | $5.24B |
| FY2017, ended Dec 31, 2017 | $4.86B | $4.87B |
| FY2018, ended Dec 31, 2018 | $5.35B | $4.86B |
| FY2019, ended Dec 31, 2019 | $4.52B | $5.37B |
| FY2020, ended Dec 31, 2020 | $5.45B | $6.61B |
| FY2021, ended Dec 31, 2021 | $5.92B | $5.85B |
| FY2022, ended Dec 31, 2022 | $5.78B | $3.84B |
| FY2023, ended Dec 31, 2023 | −$7.00B | $5.07B |
| FY2024, ended Dec 31, 2024 | $4.17B | $638M |
| FY2025, ended Dec 31, 2025 | $3.25B | $1.40B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.54B | $2.68B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.40B |
| FY2017, ended Dec 31, 2017 | $3.05B |
| FY2018, ended Dec 31, 2018 | $2.85B |
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | $4.63B |
| FY2021, ended Dec 31, 2021 | $4.56B |
| FY2022, ended Dec 31, 2022 | $3.65B |
| FY2023, ended Dec 31, 2023 | $5.93B |
| FY2024, ended Dec 31, 2024 | $5.60B |
| FY2025, ended Dec 31, 2025 | $5.24B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $4.83B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $11.5B |
| FY2017, ended Dec 31, 2017 | $13.2B |
| FY2018, ended Dec 31, 2018 | $14.2B |
| FY2019, ended Dec 31, 2019 | $19.4B |
| FY2020, ended Dec 31, 2020 | $18.8B |
| FY2021, ended Dec 31, 2021 | $17.4B |
| FY2022, ended Dec 31, 2022 | $15.9B |
| FY2023, ended Dec 31, 2023 | $16.0B |
| FY2024, ended Dec 31, 2024 | $13.0B |
| FY2025, ended Dec 31, 2025 | $12.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $15.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 13.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 596M |
| FY2017, ended Dec 31, 2017 | 596M |
| FY2018, ended Dec 31, 2018 | 576M |
| FY2019, ended Dec 31, 2019 | 576M |
| FY2020, ended Dec 31, 2020 | 579M |
| FY2021, ended Dec 31, 2021 | 571M |
| FY2022, ended Dec 31, 2022 | 551M |
| FY2023, ended Dec 31, 2023 | 553M |
| FY2024, ended Dec 31, 2024 | 543M |
| FY2025, ended Dec 31, 2025 | 527M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 517M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.75B | $298M |
| FY2017, ended Dec 31, 2017 | $2.07B | $324M |
| FY2018, ended Dec 31, 2018 | $4.87B | $302M |
| FY2019, ended Dec 31, 2019 | $1.41B | $278M |
| FY2020, ended Dec 31, 2020 | $368M | $262M |
| FY2021, ended Dec 31, 2021 | $2.20B | $274M |
| FY2022, ended Dec 31, 2022 | $1.46B | $263M |
| FY2023, ended Dec 31, 2023 | $33.0M | $274M |
| FY2024, ended Dec 31, 2024 | $1.80B | $289M |
| FY2025, ended Dec 31, 2025 | $3.25B | $225M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.78B | $210M |
Valuation
At current price- Market Cap
- $88.7B
- P/E
- 25.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.5×
- Price / Book
- 21.5×
- EV / EBITDA
- 16.0×
Growth
Trailing 12 months- Revenue (TTM)
- $25.2B
- Revenue Growth YoY
- 1.7%
- Revenue CAGR 3Y
- −1.6%
- Revenue CAGR 5Y
- −5.0%
- EPS Growth YoY
- 6.9%
- Net Income Growth YoY
- 4.0%
Profitability
Trailing 12 months- Gross Margin
- 39.5%
- Operating Margin
- 18.8%
- Net Margin
- 14.0%
- FCF Margin
- 10.6%
- Return on Equity
- 80.8%
Earnings
Trailing 12 months- Net Income
- $3.54B
- EPS (diluted)
- $6.70
- EBITDA
- $6.16B
- Operating Income
- $4.74B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $4.83B
- Total Debt
- $15.0B
- Net Debt
- $10.2B
- Total Assets
- $39.5B
- Total Liabilities
- $34.4B
- Shareholders' Equity
- $4.13B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.63B
- Capital Expenditure
- $952M
- Free Cash Flow
- $2.68B
Dividends and risk
Last 12 months- Dividend Yield
- 1.8%
- Dividend / Share
- $3.07
- Beta (5Y)
- 0.99
Every ratio is calculated from the company’s reported figures.